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Abstract
Background: Cyclosporin A (CsA) is well known as an immunosuppressive drug useful for allogeneic transplantation. It has
been reported that CsA inhibits hepatitis C virus (HCV) genome replication, which indicates that cellular targets of CsA
regulate the viral replication. However, the regulation mechanisms of HCV replication governed by CsA target proteins have
not been fully understood.
Principal Findings: Here we show a chemical biology approach that elucidates a novel mechanism of HCV replication. We
developed a phage display screening to investigate compound-peptide interaction and identified a novel cellular target
molecule of CsA. This protein, named CsA associated helicase-like protein (CAHL), possessed RNA-dependent ATPase
activity that was negated by treatment with CsA. The downregulation of CAHL in the cells resulted in a decrease of HCV
genome replication. CAHL formed a complex with HCV-derived RNA polymerase NS5B and host-derived cyclophilin B
(CyPB), known as a cellular cofactor for HCV replication, to regulate NS5B-CyPB interaction.
Conclusions: We found a cellular factor, CAHL, as CsA associated helicase-like protein, which would form trimer complex
with CyPB and NS5B of HCV. The strategy using a chemical compound and identifying its target molecule by our phage
display analysis is useful to reveal a novel mechanism underlying cellular and viral physiology.
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Introduction
Cyclosporin A (CsA) possesses immunosuppressive effects and is
widely used for allogeneic transplantation [1]. These therapeutic
effects of CsA, in particular downregulation of interleukin 2 (IL-2)
production by T cells, are considered to be responsible for the
suppression of immunological events via cellular immunology
[2,3]. Its mechanism is widely believed to include CsA binding to
its primary cytoplasmic receptor cyclophilin A (CyPA). This CsA/
CyPA complex inhibits the phosphatase activity of calcineurin,
which is essential for the activation of nuclear factor of activated T
cells (NFAT) transcription factors and their downstream cytokine
production [2–5]. The cyclophilins (CyP), identified as cytoplasmic
receptors for CsA are a family of peptidylprolyl cis-trans
isomerases (PPlase) and include more than ten subtypes [6–8].
Recently, it was reported that several CyPs regulated hepatitis C
virus (HCV) replication; CyPA binds to HCV NS5A and NS5B
proteins. CyPB also interacted with HCV NS5A and NS5B [9–
11]. The interaction of CyPB stimulates the RNA binding activity
of NS5B. These viral-cellular interaction mechanisms were
revealed by a chemical biological analysis focusing on an anti-
viral characteristic of CsA. However, it has not been fully
understood how a series of CsA-target proteins regulate HCV
replication. We obtained the data suggesting the possibility that
CsA target factor(s) other than CyP family also modify HCV
replication.
To exploit a novel drug target is a challenging but a powerful
strategy to elucidate unknown aspects of cellular physiology that
are modified by the compound. In this study, we identify a CsA
binding factor by a phage display method. There are various
methods to isolate targets of small molecules. Most of the methods,
however, require tagged small molecules for screening to separate
the drug and protein complex. The steps to synthesize tagged
small molecules are technically limited in the case of complicated
molecules such as CsA. To overcome this limitation, we recently
developed a labeling method that can be theoretically utilized for
PLoS ONE | www.plosone.org 1 April 2011 | Volume 6 | Issue 4 | e18285any chemical substance [12]. A highly reactive carbene induced by
UV irradiation reacts with CsA, resulting in the production of
immobilized CsA in a nonspecific manner. By using the
photoaffinity method, we successfully immobilized CsA on resins
and performed phage display screening. This method cloned a
CsA associated helicase-like protein, which we termed CAHL, and
this protein was shown to interact with HCV replication
machinery. Our result presents an example for the chemical
biological method that could facilitate to reveal a mechanism of
viral-cellular interaction.
Results
Phage display screening with immobilized CsA isolated
CsA associated helicase-like protein, CAHL
To explore CsA binding proteins, we applied a chemical biology
approach. In general, small molecule is necessary to be chemically
modified such as biotinylated to be immobilized on solid surface
for isolation of binding proteins. However, due to the structural
complexity of CsA, it is technically challenging to chemically
modify a certain residue of CsA. Therefore, we took advantage of
photoaffinity coupling method, which we previously developed
[12]. The highly reactive carbene induced by UV irradiation
reacted with CsA, resulting in the production of immobilized CsA
on solid surface in a nonspecific manner (Fig. 1A). We performed
phage display screening with multiple cycles that consist of
binding, washing, recovery and amplification (Fig. 1B). We used
phage particles randomly displayed 12 amino acids as a library
[13]. Through the screening cycles, the ratios of eluted phage
particles associated with CsA-immobilized resins comparing to
input were dramatically increased (Fig. 1C). We randomly picked
up 22 single phage clones from the sixth panning elution (Table
S1). Five out of the 22 phage clones were identical, and we called it
phage #13. In order to validate the binding specificity of the
phage, we amplified phage #13 and measure the ratio of eluted
phage titer with CsA and mock resins, which were treated with
MeOH to block photoaffinity reaction. The ratio of the phage
#13 was 3.75, whereas randomly picked up phage was 1.00.
These results indicated that the phage #13 specifically associated
with CsA-immobilized resins.
CAHL has an RNA-dependent ATP hydrolysis activity
Phage #13 was predicted to display amino acids, LVFGTLLG-
QLRA, in the carboxyl terminus of its phage-coat protein, which is
responsible for interaction with CsA. We searched the protein
database to find proteins that showed similarities to the
LVFGTLLGQLRA sequence. As a result of the search, we found
a protein with a sequence identical to LLGQLRA, encoded by a
gene accession number NM_022828 in the NCBI database.
NM_022828 is predicted to encodes 1430 amino acid protein that
has a couple of conserved domains, such as DEXHc helicase,
RNA-dependent ATPase and ankyrin repeat (Fig. 2A; Fig S1).
LLGQLRA sequence is located in the middle region of the protein
(amino acids 940–946), where is no known conserved motif is
found (Fig. 2A). Since it has not been reported on its biological
functions, hereafter we refer to the NM_022828 as CsA-associated
helicase-like protein, CAHL. To confirm the interaction between
CAHL and CsA, we prepared a recombinant C-terminal protein
of CAHL (named CAHL-C) that consisted of amino acids 761 to
1430 (Fig. 2B) including LLGQLRA motif, and performed surface
plasmon resonance (SPR) analysis. It was difficult to use a full-
length CAHL for in vitro pull-down assays since obtaining enough
amount of full-length CAHL for SPR was technically challenging
due to high insolubility. Considering that CsA binding sequence
found by the phage display screening is located C-terminus of
CAHL, we used CAHL-C protein. A specific binding response
with CsA was observed (KD=1.2610
-7 M), whereas those with
FK506, which is an immunosuppressant and has no HCV-
inhibitory activity, were significantly weak (KD=2.5610
-6 M)
(Fig. 2C). Since CAHL was predicted to be RNA-dependent
ATPase based on conserved domains (Fig. 2A), we measured the
ATPase activity of CAHL in the presence and absence of RNA. As
shown in Fig.2D, RNA-dependent ATP hydrolytic activity of
CAHL-C was clearly observed, and this activity was suppressed in
Figure 1. Immobilization of CsA and phage display screening.
(A) A schematic diagram of CsA immobilization on photoaffinity resins.
(B) Procedure of phage display screening. (C) Relative enrichment of
phage particles. Relative enrichment was determined by the relation-
ship between phage titer of elution from a CsA immobilized resins and
input.
doi:10.1371/journal.pone.0018285.g001
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difference of inhibitory effects of CsA and FK506 on CAHL-C
hydrolytic activity is more than 2-orders of magnitude. Consid-
ering that the difference of KDs of CsA and FK506 values
measured by SPR, CsA association with CAHL would signifi-
cantly affect on the activity. These results indicate that CAHL had
RNA-dependent ATPase activity and was specifically inhibited by
CsA.
CAHL is localized in ER and its expression is up-regulated
by TNF-a treatment
Since biological functions of CAHL were unknown, we
investigated the biological background of the CAHL gene. We
first performed RNA blotting analysis and RT-PCR using normal
human tissues and tumor cells. As shown in Fig. 3A, CAHL-
transcripts with approximately 1.6 kbp were detected in both
human hepatoma Huh-7 cells and MH-14 cells, which do not and
do carry the HCV subgenome replicon, respectively, whereas
much less was detected in normal liver tissues. RT-PCR analysis
revealed that in other normal tissues (though not testis) little or no
expression of CAHL was observed as compared the house-keeping
gene G6PDH, whereas clear expression of it was detected in all the
tumor cell lines examined (Fig. 3B). Since the CAHL expression
was very little in the normal liver tissues, a question was arisen:
how is CAHL expression regulated? It is possible that CAHL
could be induced by inflammation caused by virus infections. To
test the hypothesis, we observed whether CAHL expressions are
induced by inflammatory signals. Indeed, CAHL in normal liver
cells was upregulated in the presence of a proinflammatory
cytokine, tumor necrosis factor (TNF)-a with dose dependent
manner (Fig. 3C), suggesting that CAHL can express to some
extent in the liver under chronic hepatitis. Next, we observed
CAHL subcellular localization in Huh-7 and MH-14 cells using an
anti-CAHL antibody (Fig. 3D). Fluorescence derived from CAHL
Figure 2. Cloning of CsA associated helicase-like protein (CAHL) by phage display screening. (A) Schematic representation of CAHL
protein. R3H (cd02325), DEXHc (cd00269), ANK (cd00204), HELICc (smart00490), HA2 (pfam04408) and YTH (pfam04146) motifs were found by a CD
search (http://www.ncbi.nlm.nih.gov/Structure/edd/wrpsb.cgi). Underline indicates a region of the LLGQRA amino acid sequence identical to the CsA-
associated sequence displayed on phage #13. (B) Purified recombinant CAHL-C protein was confirmed by SDS-PAGE analysis (arrow). Asterisk
indicates degraded products. (C) A kinetic plot and binding isotherm for binding of CsA (closed circle) and FK506 (opened square) to CAHL-C sensor
chips in concentrations ranging from 0.25 to 2.5 mM. The estimated KD value of interaction between CAHL-C and CsA or FK506 was 1.2610
27 or
2.5610
26 M, respectively. (D) RNA-dependent ATP hydrolytic activities of CAHL. Filled and open circles indicate ATP hydrolytic activities of CAHL in
the presence (closed circle) or absence (opened circle) of total RNA extracted from liver cells, respectively. (E) CsA inhibitory effects on ATP hydrolytic
activities of CAHL. Filled and open circles indicate ATP hydrolytic activities with CsA (closed circle) or FK506 (opened circle), respectively.
doi:10.1371/journal.pone.0018285.g002
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a marker for endoplasmic reticulum (ER) in both the presence
(MH-14 cells) and absence (Huh-7 cells) of the HCV subgenome,
indicating that CAHL could localize in ER with HCV
independent manner. Moreover, it was observed that CAHL also
colocalized with HCV-derived proteins such as NS3, NS4A,
NS4B, NS5A and NS5B localized in ER (Fig. S2). Thus, these data
strongly suggested that CAHL would localize in ER.
Association of CAHL, NS5B and CyPB
Since CAHL interacts CsA, which has inhibitory effects to
HCV replication, it is interesting to investigate the molecular
interactions of CAHL and HCV-derived molecules involving the
replication machinery. Intriguingly, the purified full-length CAHL
fused to GST was coprecipitated with NS5B but not NS3, NS4B
or NS5A protein, as shown in Fig. 4A. To determine a regions of
NS5B responsible for binding with CAHL, various dissected NS5B
proteins were subjected to pull-down assays, resulting in that two
separated regions (1–200 aa or 401–520 aa) of NS5B were
sufficient for the interaction with CAHL (Fig. 4B). In addition to
the CAHL and NS5B interaction, we found interaction between
CAHL and CyPB, but not CyPA (Fig. 4C). The interaction of
CAHL and CyPB was disrupted with presence of CsA, whereas
the association of CAHL with NS5B was not (Fig. 4D). These
results suggest that trimer complex consisting of CAHL, CyPB and
NS5B could form.
CAHL has a main role in HCV-replication via NS5B
The finding that CAHL structurally associated with the CyPB/
NS5B complex in cell-free assessment prompted us to examine
whether this trimer complex could act for HCV genome
replication in vivo. First, five small interference RNAs (siRNA)
Figure 3. Expression profile of CAHL. (A) For Northern blot analysis, CAHL and G6PDH as an internal control were detected in RNAs derived from
Huh-7 and MH-14 cells, as well as normal liver tissues. (B) RT-PCR analysis for CAHL, and G6PDH as an internal control, were performed using RNAs
derived from normal human tissues and tumor cells. (C) CAHL in normal liver cells was upregulated by TNF-a. Normal liver cells were cultured in the
presence of proinflammatory cytokines, IL-1b, TNF-a, and IL-6 at the indicated concentrations for 8 h. Subsequently, cells were harvested, and
measurement of these cells derived-CAHL gene expression by quantitative analysis by was performed using the LightCycler system. These data
represent as relative rates (1= non-treated cells). Error bars represent the standard error of the mean. (D) Colocalization of CAHL with KDEL as an
endoplasmic reticulum (ER) marker. Indirect immunofluorescence analysis was performed on Huh-7 and MH-14 cells. Cells stained with anti-CAHL
(panels a and d, green) and an anti-KDEL mAb (panels b and e, red) for ER identification as a marker used as a primary antibody followed by Alexa
Fluor 488-conjugated goat anti-rabbit and 594-conjugated goat anti-mouse antibodies, respectively. Merged images of green and red signals are
shown in panels c and f.The optically merged image is representative of most cells examined by laser confocal microscopy. Original magnification:
x1000.
doi:10.1371/journal.pone.0018285.g003
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transfected into MH-14 cells to examine RNA sequence induced
effectively down-regulation. When si-3 siRNA was transfected into
cells, the endogenous CAHL gene expression reduced approxi-
mately 90% compared with si-control (treatment with siRNA for
non-target gene) (Fig. S3), and among them, si-3 induced down-
regulationof CAHL gene expression most effectively. Subsequently,
we applied short hairpin RNA (shRNA) technology to stably
knockdown CAHL gene expression in MH14 cells. We cloned
DNA oligo coding the effective siRNA against CAHL gene into
pLKO.1-puro shRNA vector. Lentivirus packed with shRNA
against CAHL (sh-CAHL) or non-targeting shRNA (sh-control)
were introduced into MH14 cells, and then these cells were cultured
in the presence puromycin. As a result, we successfully obtained
stably CAHL gene knockdown cell line, which reduced approxi-
mately to 6-fold compared with sh-control (Fig. 5A). In these sh-
CAHL cells, HCV RNA was decreased approximately to 4-fold less
than that in the sh-control cells (Fig. 5B). Furthermore, ectopic
expression of CAHL increased the HCV replication level in a dose-
dependent manner (Fig. 5C). These results suggest that CAHL
positively plays in HCV replication.
To investigate the outcome of the interaction of CAHL with
NS5B/CyPB, we performed RNA binding activity assay using sh-
CAHL cells. NS5B is a viral RNA-dependent RNA polymerase
and possesses RNA binding activity [11]. Indeed, NS5B formed a
complex on RNA-immobilized sepharose together with CyPB and
CAHL (lane 4 in Fig. 6A). However, shRNA-mediated depletion
of endogenous CAHL dissociated CyPB from the NS5B/RNA
complex (lane 6 in Fig. 6A), indicating that CAHL mediates the
association of CyPB with NS5B/RNA. Moreover, when CsA was
added to sh-CAHL cells, both CAHL and CyPB were dissociated
from RNA (lane 6 in Fig. 6B). Thus, the possibility is suggested
that the promotion of CyPB-NS5B complex association by CAHL
is related with the stimulatory role of CAHL in HCV replication.
Figure 4. CAHL interacted with HCV NS5B and CyPB. (A) [
35S]-labeled in vitro translation products of HCV NS3, NS4B, NS5A, and NS5B were
incubated with a recombinant GST fusion protein of CAHL (GST-CAHL) or GST as a negative control. ‘‘1/5 input’’ designates the signal for 1/5 the
amount of the [
35S]-labeled product used in the pull-down assay. CBB staining patterns for the pulled-down proteins are shown in the bottom panel.
(B) Mapping of the regions of NS5B responsible for the interaction with CAHL. At the left of the panel, schematic representations of the full-length
and truncated mutants of NS5B are shown. The numbers indicate the amino acid residue numbers in NS5B. ‘‘CAHL binding’’ summarizes the results of
the GST pull-down assay by +/2. GST pull-down data are presented as described in (A). (C) GST pull-down assay between GST-CAHL and in vitro
translated CyPA or CyPB was performed as described in (A). (D) The interaction of CAHL with CyPB was disrupted by CsA treatment. GST pull-down
assay between GST-CAHL and NS5B was performed in the absence and presence of CsA. The concentrations of CsA in lanes 4–7 are 1, 2, 8, and 20 mg/
ml, respectively.
doi:10.1371/journal.pone.0018285.g004
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Phage display, invented by Smith and Petrenko, is a versatile
method for the detection of small molecule-binding proteins [14].
The technique can also be used to identify binding sites within the
target protein itself. The combination of screening a library of
phage-displayed peptides and analysis of affinity-selected peptides
is anticipated to become a powerful tool for identifying drug-
binding sites [15–19]. Screening phage display libraries generally
entails immobilizing the drug onto a solid surface [20]. In the
conventional method of phage display, small molecules should be
converted into biotinylated derivatives and immobilized on a
streptavidin-coated matrix. Conventional immobilization requires
Figure 5. Establishment stably CAHL knockdown cell. (A)
Lentivirus packed with shRNA against CAHL (sh-CAHL) or non-targeting
shRNA (sh-control) were introduced into MH14 cells. Total RNAs were
harvested and the absolute mRNA copy numbers of CAHL were
examined by quantitative real time RT-PCR. (B) The same samples of
total RNAs were used for the measurement of the absolute RNA copy
number of the HCV genome by quantitative real time RT-PCR. (C) Cured
MH-14 cells were transfected with LMH14 RNA reporter together with
the expression plasmid for CAHL or the corresponding empty vector. At
four days post-transfection, luciferase activities were measured. These
results (A–C) represent the means of three independent experiments.
doi:10.1371/journal.pone.0018285.g005
Figure 6. CAHL associated with the CyPB/NS5B complex plays
critical roles in HCV replication. (A) Cells (sh-control or sh-CAHL
cells) were harvested and analyzed protein expressions by using anti-
CAHL, anti-NS5B, and anti-CyPB antibodies. White arrows indicate CAHL
protein. (B) Cells were treated with or without 2 mg/ml CsA for 24 h, and
then harvested and analyzed. These results were reproduced in three
independent experiments. White arrows indicate CAHL protein.
doi:10.1371/journal.pone.0018285.g006
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molecule as well as a multistep process to prepare the biotinylated
derivatives. In contrast to biotinylation, photoimmobilization
makes it possible to covalently immobilize drugs on a solid surface
without the need for derivatization. We and Kanoh et al. have
reported the affinity purification of proteins using affinity matrices,
in which small molecules are photoimmobilized by photoreaction
[12,21]. Because the photoreaction proceeds in a functional
group-independent manner, the molecules are immobilized onto
the solid surface in a nonoriented fashion. Thus, photoimmobi-
lization can be a useful tool for the comprehensive analysis of
drug-binding proteins.
Using this method, we identified CAHL as a novel target
protein for CsA. CsA is a natural compound showing multiple
biological activities, including an immunosuppressive function,
anti-chaperone activity, inhibition of transporter activity and anti-
viral activity against human immunodeficiency virus and HCV.
Thus far, p-glycoprotein and formyl peptide receptor, as well as
CyPs, were reported as binding proteins for CsA [22], which
enabled elucidation of the mechanism of the CsA-induced
immunosuppressive function, anti-chaperone activity and anti-
transporter activity, respectively. Although CyPA promotes HCV
replication [11,23,24], we cannot fully explain the whole mode of
action of CsA against HCV. CyPB is also reported to regulate
HCV replication. It was reported that the HCV replicon showing
resistance against the CsA-mediated anti-HCV effect possessed
mutations in the coding region for NS5A and NS5B [25,26],
indicating that NS5B was one of the determinants for the
sensitivity to CsA. However, some such mutations within the
NS5B coding region were dropped outside the region interacting
with CyPA and CyPB [11,24], leading to the possibility that
another cellular protein which is targeted by CsA, binds to NS5B
and regulates HCV replication. The CAHL-NS5B regulation
machinery is consistent with this idea. Deletion analysis for NS5B
demonstrated that two separate regions (1-200aa and 401-520aa)
of NS5B are likely to be involved in the interaction with CAHL.
These regions are different from the NS5B domain interacting
with CyPB (521-591aa) [11], suggesting that NS5B would interact
with both CyPB and CAHL at the same time. Indeed, the
mutations that induced resistant to CsA, the I432V in NS5B reside
inside the regions interacting with CAHL (1-200 aa and 401-520
aa) [26], supported the relevance of CAHL in HCV genome
replication. As another aspect, it is interesting that two CsA target
molecules interact with each other and NS5B. Although we do not
know in detail the implication of the interaction of these two CsA
target molecules, CyPB and CAHL, there is a similar example
already known: two FK506-binding proteins, P-glycoprotein (P-
gp) and FKBP42, associate with each other [27]. In this situation,
FKBP42 modulates P-gp function. We do not know in detail how
these two target molecules of CsA, CyPB and CAHL both regulate
NS5B function, which is a future subject of the study. Currently, a
CsA derivative shows remarkable anti-HCV effect in chronic
HCV-infected patients in the phase II clinical trial, and its mode of
action needs to be fully clarified [28]. Our data suggest a new link
of CAHL, in addition to CyP family, with CsA derivative’s anti-
HCV activity.
Cellular RNA helicases have been reported to be involved in
HCV genome replication. DDX3 and DDX6 activate HCV
genome replication through yet unknown mechanism [29,30].
RNA helicase p68 (DDX5) interacts with NS5B and supports
HCV genome replication in a transient transfection assay [31].
Although the mechanism through which each RNA helicase
regulates HCV genome replication may be different, the
requirement of cellular RNA helicases for HCV genome
replication is interesting for understanding HCV-cellular factors
interaction.
CAHL expression in normal liver cells was much less than that
in HCV infectious cells such as Huh-7 and MH-14. This is
enigmatic since it is not clear how HCV replication start without
CAHL, which positively plays HCV replication, at very beginning
of HCV infection in normal liver cells. It was reported that a
proinflammatory cytokine, TNF-a gene expression in hepatocytes
and mononuclear cells derived from HCV carrier increased
compared with healthy control [32]. As we here demonstrated
CAHL induced by TNF-a, CAHL can express to some extent in
the liver under chronic hepatitis C. We also show the association
of CAHL with HCV replication. Taken together, CAHL may
form a positive feedback loop for HCV replication: CAHL gene
expression is induced by TNF-a that is highly upregulated by
HCV infection, and CAHL in turn promotes HCV replication.
Despite the low expression of CAHL in normal tissues, CAHL
may have strong potential as a pharmaceutical target protein. In
addition to CsA, isolation of specific inhibitors to the interaction of
CAHL and NS5B could allow us to provide effective drug for
HCV treatment.
In conclusion, we took advantage of strategy of chemical biology
to isolate a cellular factor, CAHL, as CsA associated helicase-like
protein, which would form trimer complex with CyPB and NS5B
of HCV. These findings not only shed a light on new HCV
treatment but also brought about great values of chemical biology
to elucidate biological mechanisms of small-molecule and protein
interactions.
Materials and Methods
Preparation of CsA-immobilized resins
CsA was purchased from Wako Pure Chemical Industries, Ltd.
(Osaka, Japan). CsA-immobilized resins were prepared on
photoaffinity resins as described previously [12]. Photoaffinity
resins treated with UV irradiation in the absence of CsA were used
for negative control.
Phage display screening
10 mg of CsA-immobilized resin was incubated in 1 ml of TBS
(50 mM Tris-HCl [pH 8.0] and 150 mM NaCl) for 12 hours or
longer before use. Phage screening conditions were performed as
previously described [20]. For each panning step, 50 ml of CsA-
immobilized resin slurry was added to 1 ml of the T7 phage
(.10
11 pfu) followed by incubation for 8 hours at 4uC. After
incubation, the bead slurry was washed 10 times by adding 1 ml of
TBST (50 mM Tris-HCl [pH=8.0], 150 mM NaCl, 0.1% Tween
20). To elute phage particles associated with resins, 100 mlo f
Escherichia coli (OD600=0.6) was added, and incubated for 10 min
at 37uC. The phage infected E. coli were transferred into 1 ml of E.
coli (OD600=0.6) and grown until lysed for three hours at 37uC
with shaking. For titer check, 10 ml of infected E. coli was used.
RNA preparation and plasmid construction
To isolate the CAHL gene, we used total RNA derived from
human liver. DNA cloning of the CAHL gene was carried out
using a SMART-cDNA isolation kit following the manufacturer’s
instructions (Clontech Laboratories, CA, USA). In some cases,
CAHL cDNA was reconstructed with pcDNA 3.1 myc-HisA
(Invitrogen Corp., CA, USA) for overexpression experiments.
Surface plasmon resonance assay
SPR analysis was performed on a BIAcore 3000 (Biacore AB,
Uppsala, Sweden). The bacterially expressed CAHL-C was
Development of Phage Screening
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dextran matrix on a CM5 sensor chip (Biacore AB) using a
standard amine coupling reaction in 10 mM CH3COONa
[pH=4.0]. Binding analyses were carried out in HBS-EP buffer
(10 mM HEPES [pH=7.4], 150 mM NaCl, 3.4 mM EDTA,
0.005% surfactant P20) containing 8% DMSO at a flow rate of
20 ml/min. Appropriate concentrations of CsA were injected over
the flow cell. CyPA or CyPB was not used as a positive control
because of two reasons: 1) those CyPs can be used for a positive
control as CsA-CyP binding, but not for CsA-CAHL binding, and
2) FK506 doesn’t bind CyPs, so that it is difficult to compare
association behaviors between FK506 and CsA. The bulk effects of
DMSO were subtracted using reference surfaces. To derive
binding constants, data were analyzed by means of global fitting
using BIAevaluation version 3.1 (Biacore AB).
Preparation of recombinant protein
CAHL-C cDNA encoding C-terminal 761 to1430 amino acids
was constructed into pET21a prokaryotic expression vector
(Merck, Darmstadt, Germany), which has a His-tag. pET21-
CAHL-C construct was transformed into E.coli BL21(DE3) strain.
After overnight induction with 0.1 mM IPTG at 20uC, recombi-
nant CAHL-C was purified by nickel column chromatography
with HisTrap (Amersham biosciences, Uppsala, Sweden) accord-
ing to a manufacturer’s procedure. To concentrate and exchange
the buffer, purified CAHL-C was concentrated up to 40 times with
PBS by using Amicon Ultra 30 (Millipore, EMD, Germany).
ATPase assay
ATPase activity was measured as described by Okanami et al.
[33]. Briefly, CAHL-C protein (500 ng) was incubated in 50 mlo f
helicase/ATPase buffer containing 1 mlo f[ c-
32P]ATP (1 Ci/
mmol) in the presence or absence of 100 ng of total RNA derived
from liver at 30uC for 30, 60, and 180 min. An aliquot (10 ml) was
removed at the appropriate time and added to 200 ml of a solution
containing 50 mM HCl, 5 mM H3PO4 and 7% activated
charcoal. After the charcoal was precipitated by centrifugation
to remove unreacted ATP, 10 ml of the supernatant was subjected
to Cerencov counting to quantitate released [
32P]phosphate.
Northern blot analysis and reverse transcription PCR (RT-
PCR) analysis
Tumor cell-derived total RNA was prepared using an RNeasy
Mini Kit (QIAGEN Inc., Hilden, Germany) according to the
manufacturer’s instructions and then reverse-transcribed to cDNA
with Transcriptor First Strand cDNA Synthesis Kit (Roche
Applied Science, Mnnheim, Germany). A reverse-transcribed
single strand DNA library of normal tissues was purchased from
Clontec, Inc. (CA, USA). In Northern blot analysis, RNA samples
were loaded to formaldehyde agarose gels and transferred onto a
Hybond N membrane (GE Healthcare UK Ltd., Buckingham-
shire, England). After UV-crosslinking, the membrane was hybrid-
ized with
32P-labeled (Rediprime II, GE Healthcare) gene-specific
probe, regions of CAHL2913-4431 and human G6PDH454-2016 and
exposed to film for autoradiography. Measurement of CAHL gene
expression by polymerase chain reaction (PCR) was performed
using GoTaq Flexi DNA Polymerase (Promega, Co. WI, U.S.A.)
and primer sets: forward primer, 59-GACGGGAAAGGAT-
TGGTCAA-39 and reverse primer, 59-CATCACTTCGTGCT-
TTTT-39 for detection of CAHL, and forward primer, 59-
GACGAAGCGCAGACAGCGTCATGGCA-39 and reverse
primer, 59-GCTTGTGGGGGTTCACCCACTTG-39 for detec-
tion of G6PDH.
Quantitative real-time RT-PCR analysis
Total RNAs reverse-transcribed to cDNA were prepared as
described above. Measurement of gene expression by quantitative
analysis was performed using the LightCycler system (Roche
Applied Science). Primers and hybridization probes were synthe-
sized by Nihon Gene Research Laboratory Inc. (Sendai, Japan).
Quantitative real time RT-PCR analyses of human glucose-6-
phosphate dehydrogenase (G6PDH) and cyclosporin A associated
helicase-like protein (CAHL, NM_022828) gene expression were
performed using the LightCyclerH FastStart DNA MasterPLUS
SYBR Green I system (Roche Applied Science) with the following
primer sets: forward primer, 59-CTGCGTTATCCTCACCTTC-
39 and reverse primer, 59-CGGACGTCATCTGAGTTG-39 for
detection of human G6PDH; forward primer, 59-GTGT-
CTGGACCCCATCCTTA-39and reverse primer, 59-CCCAT-
CACTTCGTGCTTTTT-39for detection of CAHL. Gene ex-
pression analysis of the HCV genome was performed using the
LightCyclerH FastStart DNA Master HybProbe system (Roche
Applied Science) with the following primer set and probe: forward
primer, 59-CGGGAGAGCCATAGTGG-39 and reverse primer,
59-AGTACCACAAGGCCTTTCG-39, and the fluorogenic
probe, 59-CTGCGGAACCGGTGAGTACAC-39. PCR amplifi-
cation of the housekeeping gene, G6PDH, was performed for each
sample as control for sample loading and to allow normalization
among samples. To determine the absolute copy number of the
target transcripts, the fragments of G6PDH or target genes
amplified by PCR using the above described primer set were
constructed with pCR4H-TOPOH cloning vector (Invitrogen). The
concentrations of these purified plasmids were measured by
absorbance at 260 nm and copy numbers were calculated from
concentration of samples. A standard curve was created by
plotting the threshold cycle (Ct) versus the known copy number for
each plasmid template in the dilutions. The copy numbers for all
unknown samples were determined according to the standard
curve using LightCycler version 3.5.3 (Roche Applied Science). To
correct for differences in both RNA quality and quantity between
samples, each target gene was first normalized by dividing the
copy number of the target by the copy number of G6PDH, so that
the mRNA copy number of the target was the copy number per
the copy number of G6PDH. The initial value was also corrected
for the amount of G6PDH indicated as 100% to evaluate the
sequential alteration of the mRNA expression level.
Cell culture and transfection of siRNA and cDNA
The human tumor cell lines of breast adenocarcinoma MDA-
MB-231, lung adenocarcinoma A-549, colon adenocarcinoma
WiDr, hepatocellular carcinoma Huh-7, breast cancer SKBR3,
cervical carcinoma HeLa, esophagus cancer KE-4, colon adeno-
carcinoma SW480, lung cancer Lu65, and esophagus squamous
cell carcinoma TE-8 were obtained from Health Science Research
Resources Bank (Sendai, Japan). These cells were cultured in
Dulbecco’s modified Eagle’s medium (Huh-7, SKBR3, HeLa, KE-
4, and SW480 cells), RPMI 1640 (A-549, WiDr, TE-8, and Lu65
cells) (SIGMA-ALDRICH, MO, USA), and Leibovitz’s L15
(MDA-MB-231 cells) (Invitrogen) supplemented with 10% fetal
bovine serum, MEM nonessential amino acids (Invitrogen),
200 unit/ml penicillin (Invitrogen), 200 mg/ml streptomycin
(Invitrogen) and 2 mM L-glutamine (Invitrogen). MH-14 cells
carrying the HCV subgenomic replicon [34] were cultured in the
DMEM medium supplemented with 10% fetal bovine serum,
MEM nonessential amino acids (Invitrogen), 200 unit/ml penicil-
lin (Invitrogen), 200 mg/ml streptomycin (Invitrogen), 2 mM L-
glutamine (Invitrogen) and 300 mg/ml G418 (Invitrogen). Five
small interfering RNA (siRNA) duplexes containing 39dTdT over
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MO). These sequences were: si-1; 59-GGACAUUCGCAUU-
GAUGAG-39, si-2; 59-CCUGUAAUUUGACUCAUAA-39, si-3;
59- GCCUUGGAUGUAAAUCUCUUU -39, si-4; 59- GGAG-
CUUUCAGUGACCAUA -39, si-5; 59-GGUCAAAUAAUA-
GUAGGAA-39. A non-targeting siRNA (Sigma-Aldrich) was used
as control. Plasmid and siRNA transfection was performed
described previously [35]. In siRNA study, total RNAs from
transfected cells were harvested after transfection for 5 days and
examined mRNA copy number of CAHL by quantitative real-
time RT-PCR.
Establishment of stable CAHL-knockdown cell by shRNA
Based on the siRNA data, we applied short hairpin RNA
(shRNA) technology platform (Sigma MissionRNAi) to stably
knockdown CAHL gene expression in MH14 cells. DNA oligo
coding the effective siRNAs against each MH14-CAHL gene (59-
CCGGGCCTTGGATGTAAATCTCTTTCTCGAGAAAGAG-
ATTTACATCCAAGGCTTTTTTG -39) (sh-CAHL) was cloned
into pLKO.1-puro shRNA vector. Plasmid DNA including non-
targeting shRNA as control (sh-control) was transfected into
MH14 cells along with Lentiviral Packaging Mix consisting of an
envelope and packaging vector (Sigma-Aldrich) to produce
lentivirus packed with shRNA cassettes using the standard
procedure. After transfection, cells were cultured in the presence
of 10 mg/ml puromycin.
Indirect immunofluorescence analysis
Anti-CAHL polyclonal antibody serum was generated in rabbits
immunized with CAHL1237-1251, ILHPKRGTEDRSDQS, ac-
cording to our lab protocol [35]. Anti-NS3, NS4B, and NS5B, and
NS5A were kindly provided from Dr. Kohara at The Tokyo
Metropolitan Institute of Medical Science, Japan and Dr.
Takamizawa at Osaka University, Japan, respectively. Cells were
fixed with ice-cold acetone for 1 min, and then stained with anti-
CAHL and anti-KDEL mAb (Santa Cruz Biotechnology, CA,
USA) for ER antibodies followed by Alexa Fluor 488-conjugated
goat anti-rabbit IgG and 594-conjugated goat anti-mouse IgG
(Invitrogen), respectively, and visualized using a Bio-Rad
MRC1024ES laser confocal scanning microscopy system (Bio-
Rad Laboratories, CA, USA).
Immunoblot analysis
Immunoblot analysis was performed essentially as described
previously [11,36].
RNA-protein binding precipitation assay
RNA-protein binding precipitation assay was essentially per-
formed as described [11]. Briefly, to permeabilize plasma
membrane, cells were treated 50 mg/ml digitonin (Nakarai Tesque
Inc., Kyoto, Japan) in buffer B (20 mM HEPES-KOH [pH=7.7],
110 mM KOAc, 2 mM MgOAc, 1 mM EGTA) at 25uC for
5 min. After treatment with 0.5 mg/ml proteinase K at 37uC for
5 min and washing with buffer B, cells were lysed in IP buffer
(50 mM Tris-HCl [pH=8], 150 mM NaCl, 0.5% NP-40, and
protease inhibitory cocktail [Roche Applied Science]). After
centrifugation, supernatants were incubated for 2 h with poly-U
or protein G Sepharose resin (GE Healthcare). After four washes
with IP buffer, precipitates were analyzed by immunoblot analysis.
Supernatants after centrifugation were used as a positive control
(designated Cell lysate in Fig. 4E and 4D).
GST-pull-down assay
GST-pull-down assay was performed as described previously
[36].
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Figure S1 Predicted amino acid sequences of CAHL
(NM_022828). Underlined residues (LLGQLRA) indicate identi-
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Figure S2 Indirect immunoflourescence analysis for colocalized
with between CAHL and NS3, NS4A, NS4B, NS5A, and NS5B
using Huh-7 (A) and MH-14 (B). The primary antibodies used
were anti-CAHL (panels a, d, g, j, and m, green) and anti-NS
proteins (panels b, e, h, k, and n, red) antibodies. Marge images of
green and red signals are shown in panels c, f, i, l, and o.
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Figure S3 Determinant of knockdown efficiency against CAHL
gene expression. Five siRNAs for the CAHL gene were
individually transfected into MH-14 cells. After transfection, total
RNAs of these cells were collected and examined mRNA copy
number of CAHL by quantitative real-time RT-PCR.
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Table S1 List of phage clones and their encoding deduced
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